Discover 4,047 paid clinical trials in Bronx, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 4,047
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Location: New York NY, Philadelphia PA, Boston MA, Baltimore MD,
Sponsor: Nuvalent Inc.
Sex: All
Age: 12+
Code: NCT05384626
Phase 1, Phase 2, Recruiting
Precision-Based Genomics in Prostate Cancer
for
Prostate Cancer
Location: New York NY, Boston MA, Bethesda MD, Evanston IL,
Sponsor: National Cancer Institute (NCI)
Sex: Male
Age: 18 - 70+
Code: NCT04706663
Recruiting
Multicenter Prospective Trial on Hemorrhoids
for
Hemorrhoids
Location: Stony Brook NY
Sponsor: Stony Brook University
Sex: All
Age: 18+
Code: NCT03245086
Recruiting
A Study of CRD3874-SI in People With Solid Tumors
for
Sarcoma, Merkel Cell Carcinoma
Location: New York NY, Harrison NY, Rockville Centre NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT06021626
Phase 1, Recruiting
Computerized Cognitive Remediation for Geriatric Depression
for
Major Depressive Disorder, Major Depressive Episode
Location: White Plains NY
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 60 - 70+
Code: NCT01979289
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Comparison of Breastfeeding Teaching Intervention
for
Breast Feeding
Location: Brooklyn NY
Sponsor: Brookdale University Hospital Medical Center
Sex: All
Age: 0+
Code: NCT03602729
Recruiting
Task Specific Training for Advanced Multiple Sclerosis
for
Multiple Sclerosis
Location: New York NY
Sponsor: Hunter College of City University of New York
Sex: All
Age: 18 - 70+
Code: NCT06506929
Recruiting
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
for
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma,
Location: New York NY, New Haven CT, Shirley NY, Hershey PA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06324357
Phase 1, Phase 2, Recruiting
Belatacept in De Novo Heart Transplantation
for
Heart Transplantation
Location: New York NY
Sponsor: NYU Langone Health
Sex: All
Age: 18 - 70+
Code: NCT04477629
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
for
Non-small Cell Lung Cancer
Location: New York NY, Athens GA, Tampa FL, Des Moines IA,
Sponsor: Teligene US
Sex: All
Age: 18+
Code: NCT06010329
Phase 2, Recruiting
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma
for
Mucosal Melanoma
Location: New York NY, Harrison NY
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT05384496
Phase 2, Recruiting
Direct Peritoneal Resuscitation for Intra-abdominal Catastrophes
Location: New York NY, Philadelphia PA, Boston MA,
Sponsor: Nuvalent Inc.
Sex: All
Age: 12+
Code: NCT05118789
Phase 1, Phase 2, Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: New York NY, Paramus NJ, New Haven CT, West Reading PA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06742996
Phase 3, Recruiting
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
for
Thyroid Carcinoma, Metastatic Thyroid Carcinoma
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT03647358
Phase 1, Recruiting
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
for
Refractory Acute Myeloid Leukemia,
Location: New York NY, Harrison NY, Rockville Centre NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 1+
Code: NCT06017258
Phase 1, Recruiting
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome